Cargando…
Author Correction: MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC
Autores principales: | Wang, Xiaoyuan, Chen, Xuesong, Meng, Qingwei, Jing, Hu, Lu, Hailing, Yang, Yanmei, Cai, Li, Zhao, Yanbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755281/ https://www.ncbi.nlm.nih.gov/pubmed/36522356 http://dx.doi.org/10.1038/s41598-022-25595-3 |
Ejemplares similares
-
MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC
por: Wang, Xiaoyuan, et al.
Publicado: (2015) -
miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC
por: Wang, Xiaoyuan, et al.
Publicado: (2018) -
14-3-3ζ/TGFβR1 promotes tumor metastasis in lung squamous cell carcinoma
por: Zhao, Yanbin, et al.
Publicado: (2016) -
Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
por: Fang, Chao, et al.
Publicado: (2021) -
Author Correction: ENMD-1068 inhibits liver fibrosis through attenuation of TGF-β1/Smad2/3 signaling in mice
por: Sun, Quan, et al.
Publicado: (2019)